Bachem is a Swiss-based pharmaceutical company with over 50 years of specialized experience. It is a global leader in the development and manufacturing of peptides and oligonucleotides, serving the pharmaceutical and biotechnology industries. The company is publicly listed.
Its core technical domains are peptide chemistry, oligonucleotide chemistry, and TIDES. The company's operations span from early-stage research support to large-scale Good Manufacturing Practice (GMP) manufacturing for active pharmaceutical ingredients.
Bachem offers custom peptide synthesis services, off-the-shelf catalog products, GMP manufacturing, and regulatory support to help clients navigate compliance requirements. The company has a global geographic presence, with its headquarters in Bubendorf, Switzerland, and operations across Europe, the United States, and Asia.
